The TWIK-related Acid Sensitive Potassium 3 (TASK-3) Channel Contributes to the Different Effects of Anesthetics on the Growth and Metastasis of Ovarian Cancer Cells

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Aug 20

PMID 39161826

Authors

Zhiqiang Hu

Qi Jia

Shanglong Yao

Xiangdong Chen

Affiliations

Soon will be listed here.

Abstract

Different anesthetics exert different effects on the long-term outcomes of various cancers. The TWIK-related acid sensitive potassium 3 (TASK-3) channel is an important target of anesthetics and is upregulated in various cancers. However, the role and underlying mechanism of TASK-3 channel in the effects of anesthetics on ovarian cancer remain unknown. Here, we tested whether the TASK-3 channel contributes to the effects of anesthetics on ovarian cancers. We found that the TASK-3 channel was overexpressed in human ovarian cancer and ovarian cancer cell lines. Clinically relevant concentrations of lidocaine, as a TASK-3 channel inhibitor, exert inhibitory effects on tumor growth and metastasis of ovarian cancer cells and , whereas the TASK-3 channel potent activator sevoflurane had protumor effects and propofol had no significant effects on tumor growth and metastasis of ovarian cancer. Knockdown of the TASK-3 channel by TASK-3 shRNA attenuated the effects of lidocaine and sevoflurane. Moreover, mitochondrial TASK-3 channel contributes to the effects of lidocaine and sevoflurane on the mitochondrial functions of ovarian cancer. Taken together, the TASK-3 channel, especially the mitochondrial TASK-3 (MitoTASK-3) channel, is a molecular substrate for the effects of lidocaine and sevoflurane on the tumor growth and metastasis of ovarian cancer.

References

Loop T, Scheiermann P, Doviakue D, Musshoff F, Humar M, Roesslein M . Sevoflurane inhibits phorbol-myristate-acetate-induced activator protein-1 activation in human T lymphocytes in vitro: potential role of the p38-stress kinase pathway. Anesthesiology. 2004; 101(3):710-21. DOI: 10.1097/00000542-200409000-00020. View

Johnson M, Crowley P, Foley A, Xue C, Connolly C, Gallagher H . Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model. Br J Anaesth. 2018; 121(1):76-85. DOI: 10.1016/j.bja.2017.12.043. View

Wigmore T, Mohammed K, Jhanji S . Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis. Anesthesiology. 2015; 124(1):69-79. DOI: 10.1097/ALN.0000000000000936. View

Jang S, Byun J, Jeon W, Choi S, Park J, Lee B . Nuclear localization and functional characteristics of voltage-gated potassium channel Kv1.3. J Biol Chem. 2015; 290(20):12547-57. PMC: 4432276. DOI: 10.1074/jbc.M114.561324. View

Nagy D, Gonczi M, Dienes B, Szoor A, Fodor J, Nagy Z . Silencing the KCNK9 potassium channel (TASK-3) gene disturbs mitochondrial function, causes mitochondrial depolarization, and induces apoptosis of human melanoma cells. Arch Dermatol Res. 2014; 306(10):885-902. DOI: 10.1007/s00403-014-1511-5. View

Kadiri N, Rodeau J, Schlichter R, Hugel S . Neurotensin inhibits background K+ channels and facilitates glutamatergic transmission in rat spinal cord dorsal horn. Eur J Neurosci. 2011; 34(8):1230-40. DOI: 10.1111/j.1460-9568.2011.07846.x. View

Yao C, Li Y, Shu S, Yao S, Lynch C, Bayliss D . TASK channels contribute to neuroprotective action of inhalational anesthetics. Sci Rep. 2017; 7:44203. PMC: 5343576. DOI: 10.1038/srep44203. View

Badwe R, Parmar V, Nair N, Joshi S, Hawaldar R, Pawar S . Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer. J Clin Oncol. 2023; 41(18):3318-3328. DOI: 10.1200/JCO.22.01966. View

Lin L, Liu C, Tan H, Ouyang H, Zhang Y, Zeng W . Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesth. 2011; 106(6):814-22. DOI: 10.1093/bja/aer055. View

10.

Ow Y, Green D, Hao Z, Mak T . Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol. 2008; 9(7):532-42. DOI: 10.1038/nrm2434. View

11.

Guagliardo N, Yao J, Stipes E, Cechova S, Le T, Bayliss D . Adrenal Tissue-Specific Deletion of TASK Channels Causes Aldosterone-Driven Angiotensin II-Independent Hypertension. Hypertension. 2018; 73(2):407-414. PMC: 6326871. DOI: 10.1161/HYPERTENSIONAHA.118.11962. View

12.

Sekandarzad M, Van Zundert A, Lirk P, Doornebal C, Hollmann M . Perioperative Anesthesia Care and Tumor Progression. Anesth Analg. 2016; 124(5):1697-1708. DOI: 10.1213/ANE.0000000000001652. View

13.

Schlereth B, Fichtner I, Lorenczewski G, Kleindienst P, Brischwein K, da Silva A . Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct. Cancer Res. 2005; 65(7):2882-9. DOI: 10.1158/0008-5472.CAN-04-2637. View

14.

Sun H, Luo L, Lal B, Ma X, Chen L, Hann C . A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis. Nat Commun. 2016; 7:10339. PMC: 4742836. DOI: 10.1038/ncomms10339. View

15.

Bonnet S, Archer S, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R . A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007; 11(1):37-51. DOI: 10.1016/j.ccr.2006.10.020. View

16.

Heerdt B, Houston M, Augenlicht L . The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression. Cancer Res. 2005; 65(21):9861-7. DOI: 10.1158/0008-5472.CAN-05-2444. View

17.

Kim C, Cho Y, Jeong S, Kim Y, Kim S, Nam S . Altered expression of KCNK9 in colorectal cancers. APMIS. 2004; 112(9):588-94. DOI: 10.1111/j.1600-0463.2004.apm1120905.x. View

18.

Mu D, Chen L, Zhang X, See L, Koch C, Yen C . Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell. 2003; 3(3):297-302. DOI: 10.1016/s1535-6108(03)00054-0. View

19.

Pocsai K, Kosztka L, Bakondi G, Gonczi M, Fodor J, Dienes B . Melanoma cells exhibit strong intracellular TASK-3-specific immunopositivity in both tissue sections and cell culture. Cell Mol Life Sci. 2006; 63(19-20):2364-76. PMC: 11136003. DOI: 10.1007/s00018-006-6166-8. View

20.

Lheureux S, Gourley C, Vergote I, Oza A . Epithelial ovarian cancer. Lancet. 2019; 393(10177):1240-1253. DOI: 10.1016/S0140-6736(18)32552-2. View